These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 35014681)

  • 1. Protein disulfide isomerase A1‑associated pathways in the development of stratified breast cancer therapies.
    Bakker EY; Fujii M; Krstic-Demonacos M; Demonacos C; Alhammad R
    Int J Oncol; 2022 Feb; 60(2):. PubMed ID: 35014681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein disulfide isomerase A1 regulates breast cancer cell immunorecognition in a manner dependent on redox state.
    Alhammad R; Khunchai S; Tongmuang N; Limjindaporn T; Yenchitsomanus PT; Mutti L; Krstic-Demonacos M; Demonacos C
    Oncol Rep; 2020 Dec; 44(6):2406-2418. PubMed ID: 33125139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subverted regulation of Nox1 NADPH oxidase-dependent oxidant generation by protein disulfide isomerase A1 in colon carcinoma cells with overactivated KRas.
    De Bessa TC; Pagano A; Moretti AIS; Oliveira PVS; Mendonça SA; Kovacic H; Laurindo FRM
    Cell Death Dis; 2019 Feb; 10(2):143. PubMed ID: 30760703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Redox Regulation of Mitochondrial Fission Protein Drp1 by Protein Disulfide Isomerase Limits Endothelial Senescence.
    Kim YM; Youn SW; Sudhahar V; Das A; Chandhri R; Cuervo Grajal H; Kweon J; Leanhart S; He L; Toth PT; Kitajewski J; Rehman J; Yoon Y; Cho J; Fukai T; Ushio-Fukai M
    Cell Rep; 2018 Jun; 23(12):3565-3578. PubMed ID: 29924999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing the contribution of the two protein disulfide isomerases PDIA1 and PDIA3 to cisplatin resistance.
    Kullmann M; Kalayda GV; Hellwig M; Kotz S; Hilger RA; Metzger S; Jaehde U
    J Inorg Biochem; 2015 Dec; 153():247-252. PubMed ID: 26364260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PDIA1/P4HB is required for efficient proinsulin maturation and ß cell health in response to diet induced obesity.
    Jang I; Pottekat A; Poothong J; Yong J; Lagunas-Acosta J; Charbono A; Chen Z; Scheuner DL; Liu M; Itkin-Ansari P; Arvan P; Kaufman RJ
    Elife; 2019 Jun; 8():. PubMed ID: 31184304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of membrane protein disulphide isomerase A1 (PDIA1) disrupt a reducing microenvironment in endometrial epithelium for embryo implantation.
    Fernando SR; Lee CL; Wong BP; Cheng KW; Lee YL; Chan MC; Ng EH; Yeung WS; Lee KF
    Exp Cell Res; 2021 Aug; 405(2):112665. PubMed ID: 34111473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the ERO1-PDI interaction in oxidative protein folding and disease.
    Shergalis AG; Hu S; Bankhead A; Neamati N
    Pharmacol Ther; 2020 Jun; 210():107525. PubMed ID: 32201313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein disulfide isomerase externalization in endothelial cells follows classical and unconventional routes.
    Araujo TLS; Zeidler JD; Oliveira PVS; Dias MH; Armelin HA; Laurindo FRM
    Free Radic Biol Med; 2017 Feb; 103():199-208. PubMed ID: 28034831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanistic study of PDIA1-catalyzed TFF3 dimerization during sepsis.
    Shi Y; Wang C; Wu D; Zhu Y; Wang ZE; Peng X
    Life Sci; 2020 Aug; 255():117841. PubMed ID: 32454156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the Influence of Zinc Ions on the Conformational Stability and Activity of Protein Disulfide Isomerase.
    Moretti AIS; Baksheeva VE; Roman AY; De Bessa TC; Devred F; Kovacic H; Tsvetkov PO
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of an A-Site Selective Protein Disulfide Isomerase A1 Inhibitor.
    Cole KS; Grandjean JMD; Chen K; Witt CH; O'Day J; Shoulders MD; Wiseman RL; Weerapana E
    Biochemistry; 2018 Apr; 57(13):2035-2043. PubMed ID: 29521097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein disulfide isomerases: Redox connections in and out of the endoplasmic reticulum.
    Soares Moretti AI; Martins Laurindo FR
    Arch Biochem Biophys; 2017 Mar; 617():106-119. PubMed ID: 27889386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A molecular dynamics approach on the Y393C variant of protein disulfide isomerase A1.
    Madero-Ayala PA; Mares-Alejandre RE; Ramos-Ibarra MA
    Chem Biol Drug Des; 2020 Dec; 96(6):1341-1347. PubMed ID: 32352225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural insight into the dimerization of human protein disulfide isomerase.
    Bastos-Aristizabal S; Kozlov G; Gehring K
    Protein Sci; 2014 May; 23(5):618-26. PubMed ID: 24549644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Estrogen Receptor Cofactor SPEN Functions as a Tumor Suppressor and Candidate Biomarker of Drug Responsiveness in Hormone-Dependent Breast Cancers.
    Légaré S; Cavallone L; Mamo A; Chabot C; Sirois I; Magliocco A; Klimowicz A; Tonin PN; Buchanan M; Keilty D; Hassan S; Laperrière D; Mader S; Aleynikova O; Basik M
    Cancer Res; 2015 Oct; 75(20):4351-63. PubMed ID: 26297734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EF24 prevents rotenone-induced estrogenic status alteration in breast cancer.
    Roy D; Kabiraj P; Pal R
    Cell Biol Int; 2014 Apr; 38(4):511-9. PubMed ID: 24375813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen receptor α dependent regulation of estrogen related receptor β and its role in cell cycle in breast cancer.
    Madhu Krishna B; Chaudhary S; Mishra DR; Naik SK; Suklabaidya S; Adhya AK; Mishra SK
    BMC Cancer; 2018 May; 18(1):607. PubMed ID: 29843638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of estrogen receptor antagonism toward p53 and its implications in breast cancer therapeutic response and stem cell regulation.
    Konduri SD; Medisetty R; Liu W; Kaipparettu BA; Srivastava P; Brauch H; Fritz P; Swetzig WM; Gardner AE; Khan SA; Das GM
    Proc Natl Acad Sci U S A; 2010 Aug; 107(34):15081-6. PubMed ID: 20696891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The proteasome inhibitor Bortezomib (Velcade) as potential inhibitor of estrogen receptor-positive breast cancer.
    Thaler S; Thiede G; Hengstler JG; Schad A; Schmidt M; Sleeman JP
    Int J Cancer; 2015 Aug; 137(3):686-97. PubMed ID: 25530422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.